Magali Gary‐Bobo

The Cannabinoid CB1 Receptor Antagonist SR141716 Increases Acrp30 mRNA Expression in Adipose Tissue of Obese fa/fa Rats and in Cultured Adipocyte Cells

M. Bensaïd, Magali Gary‐Bobo, A. Esclangon et al. · Molecular Pharmacology · 2003 · 595 citations

Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats

Magali Gary‐Bobo, Ghizlane Elachouri, Jean François Gallas et al. · Hepatology · 2007 · 302 citations · Full text

Metabolic Disorder, Pathology, Fatty Liver Disease +17

Mannose‐Functionalized Mesoporous Silica Nanoparticles for Efficient Two‐Photon Photodynamic Therapy of Solid Tumors

Magali Gary‐Bobo, Y. Mir, Cédric Rouxel et al. · Angewandte Chemie International Edition · 2011 · 248 citations

Mannose-targeted mesoporous silica nanoparticles for photodynamic therapy

David Brevet, Magali Gary‐Bobo, Laurence Raehm et al. · Chemical Communications · 2009 · 240 citations · Full text

Nanoparticles, Nanomedicine, Pdt Applications +15

Cancer therapy improvement with mesoporous silica nanoparticles combining targeting, drug delivery and PDT

Magali Gary‐Bobo, Ouahiba Hocine, David Brevet et al. · International Journal of Pharmaceutics · 2011 · 181 citations

Nanoparticles, Nanomedicine, Mesoporous Silica Nanoparticles +9